Recent developments in nitric oxide donor drugs

M R Miller, I L Megson

Research output: Contribution to journalReview articlepeer-review

512 Citations (Scopus)


During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial signalling molecule, with wide-ranging functions in the cardiovascular, nervous and immune systems. Aside from providing a credible explanation for the actions of organic nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises respectively, the discovery generated great hopes for new NO-based treatments for a wide variety of ailments. Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end. This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges associated with NO as a therapeutic agent.
Original languageEnglish
Pages (from-to)305-21
Number of pages17
JournalBritish Journal of Pharmacology
Issue number3
Publication statusPublished - 2007


Dive into the research topics of 'Recent developments in nitric oxide donor drugs'. Together they form a unique fingerprint.

Cite this